黑色素瘤脑转移小鼠模型立体定向放射外科的质量评估:小鼠仿体与SARRP平台
研究建立小鼠黑色素瘤脑转移立体定向放射外科(SRS)临床前模型,联合小鼠仿体进行质量保证。C57B6小鼠颅内注射B16-F10细胞,11天后MRI融合CBCT勾画GTV,单弧3×3 mm²准直器处方18 Gy至等中心。治疗后7天SRS组肿瘤体积显著小于未SRS组(P=.009),SRS组中位总生存未达到。
要点
- MRI T1增强融合CBCT可精确勾画小鼠脑转移GTV并制定单弧SRS计划。
- 小鼠仿体胶片面剂量分布与计划等剂量线吻合,可验证给药精度。
- 18 Gy单次SRS显著抑制肿瘤生长并改善生存,对照组中位生存19天。
核心结论
- 单次18 Gy单弧SRS基于MRI T1增强计划可准确实施,小鼠仿体可验证剂量投递与精度。
研究设计与样本
- C57B6小鼠颅内注射B16-F10黑色素瘤细胞建立脑转移模型,注射后11天行T1加权增强MRI。
- MRI与CBCT融合,基于MRI勾画GTV,使用SARRP以3×3 mm²准直器单矢状弧处方18 Gy至等中心。
- 采用2个小鼠仿体(轴向和矢状位各1)验证剂量,并使用PTW Farmer型电离室按AAPM TG-61测量SARRP输出并生成至30 Gy的H-D曲线。
主要发现
- 干预前第11天肿瘤体积:未SRS组2.48±1.37 mm³,SRS组3.75±1.19 mm³(NS)。
- SRS组GTV最大剂量(Dmax)和平均剂量分别为2048±207 cGy和1785±14 cGy。
- 小鼠仿体胶片显示与计划等剂量线精度接近,轴向和矢状位仿体Dmax分别为1903.4和1972.7 cGy。
- 治疗后7天肿瘤体积:SRS组7.34±8.24 mm³,未SRS组60.20±40.4 mm³(P=.009)。
- 对照组无小鼠在植入后存活超过22天,中位总生存(mOS)19天;SRS组mOS未达到,仅1例死亡。
临床怎么用
- 该临床前模型可用于脑转移SRS的剂量学与疗效评估,小鼠仿体可作为质量保证工具验证剂量投递精度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To establish a novel preclinical model for stereotactic radiosurgery (SRS) with combined mouselike phantom quality assurance in the setting of brain metastases. METHODS AND MATERIALS: C57B6 mice underwent intracranial injection of B16-F10 melanoma cells. T1-weighted postcontrast magnetic resonance imaging (MRI) was performed on day 11 after injection. The MRI images were fused with cone beam computed tomography (CBCT) images using the Small Animal Radiation Research Platform (SARRP). The gross tumor volume (GTV) was contoured using the MRI. A single sagittal arc using the 3 × 3 mm2 collimator was used to deliver 18 Gy prescribed to the isocenter. MRI was performed 7 days after radiation treatment, and the dose delivered to the mice was confirmed using 2 mouselike anthropomorphic phantoms: 1 in the axial orientation and the other in the sagittal orientation. The SARRP output was measured using a PTW Farmer type ionization chamber as per the American Association of Physicists in Medicine Task Group report 61, and the H-D curve was generated up to a maximum dose of 30 Gy. Irradiated films were analyzed based on optical density distribution and H-D curve. RESULTS: The tumor volume on day 11, before intervention, was 2.48 ± 1.37 mm3 in the no-SRS arm versus 3.75 ± 1.19 mm3 in the SRS arm (NS). In the SRS arm, GTV maximum dose (Dmax) and mean dose were 2048 ± 207 and 1785 ± 14 cGy. Using the mouselike phantoms, the radiochromic film showed close precision in comparison with projected isodose lines, with a Dmax of 1903.4 and 1972.7 cGy, the axial and sagittal phantoms, respectively. Tumor volume 7 days after treatment was 7.34 ± 8.24 mm3 in the SRS arm and 60.20 ± 40.4 mm3 in the no-SRS arm (P=.009). No mice in the control group survived more than 22 days after implantation, with a median overall survival (mOS) of 19 days; mOS was not reached in the SRS group, with 1 death noted. CONCLUSIONS: Single-fraction SRS of 18 Gy delivered in a single arc can be delivered accurately with MRI T1-weighted postcontrast-based treatment planning. The mouse like phantom allows for verification of dose delivery and accuracy.
引用
- Wu CC, Chaudhary KR, Na YH, et al. Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816146. doi:10.1016/j.ijrobp.2017.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。